Find the investors funding Health Seed rounds
326,000+ VC, angel and family-office profiles — direct emails, check sizes and stage filters.
France's AbTx raises €1.7M seed for miniaturised cancer antibodies - Dealroom
AbTx is a French biotechnology startup founded in 2024, developing a new generation of antibody-drug conjugates (ADCs) for solid tumors. Their patented Therano-Stick platform uses enzymatic bio-conjugation to create miniaturized ADCs called fragment drug conjugates (FDCs). This seed round aims to validate their novel platform in the competitive ADC field.
France's AbTx raises €1.7M seed for miniaturised cancer antibodies Dealroom
| Nov 02, 2026 | Gallium Defense | $7 | Seed | France |
| Nov 02, 2026 | Fibraterre | $2.0M | Seed | France |
| Oct 23, 2026 | Mistral | $3.00B | Series D | France |
| Oct 18, 2026 | CarbonFarm | $7.8M | Series A | France |
You just read who funded AbTx. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.
Free account: 15 investor contact unlocks a month, no card required.